Virtual Reality Based Vision Test in Patients With AMD — GA-001  

Age-Related Macular Degeneration Clinical Trial

Official title: Virtual Reality (VR) Based Vision Test in Subjects With Age-related Macular Degeneration (AMD)

Status Recruiting

Clinical Trial Summary

To assess the usability, tolerability, and repeatability of the set of VR headset-based tasks.

Clinical Trial Description

In order to bridge the gap between the existing functional measures and AMD lesions, researchers are considering the use of VR tools. This study is designed to assess the contrast sensitivity function mapping test (CSF radial sweep) in an elderly population with AMD. The primary objective of this study is to assess the usability, tolerability, and repeatability of the set of VR headset-based tasks. The secondary objective of this study is to assess the relationship between the metrics generated by VR-based functional tasks and the metrics derived from conventional clinical measurements of retinal anatomy and visual function. The primary efficacy endpoint is the Contrast sensitivity function (CSF) area under curve (AUC) correlation to Snellen BCVA. ;

Related Conditions & MeSH terms

• Age-Related Macular Degeneration
• Macular Degeneration

• NCT number: NCT06241625
• Study type: Interventional
• Source: Augenklinik Zurich West
• Contact: Stephan Michels, MD
• Phone: +414454517
• Email: info@augenklinik-zh.ch
• Status: Recruiting
• Phase: N/A
• Start date: October 20, 2022
• Completion date: July 2024